ebook Munafa Stock Market Course + Intraday & FNO calls  

       

SW0I announcements S&p Developed Ex-u.s.bmi [capped] announcements and dividends declared INDICES

S&p Developed Ex-u.s.bmi [capped] Complete list of announcements declared & dividend announcements by S&p Developed Ex-u.s.bmi [capped] SW0I

S&p Developed Ex-u.s.bmi [capped] SW0I listed on INDICES and deals in

Announcements and dividends declared by S&p Developed Ex-u.s.bmi [capped] SW0I

3 Retail REITs Poised to Gain From Resilient Demand and Limited Supply
SPG, KIM and REG look set to benefit as need-based retail demand holds up and limited new supply supports rents, occupancy and values.
Announcement as on 22 April 2026

Earnings Picture Remains Positive: A Closer Look
The picture emerging from the Q1 earnings season is of continued strength and momentum, with companies not only comfortably beating consensus estimates but also providing a reassuring read on the economy despite elevated energy costs and other risks.
Announcement as on 22 April 2026

USFDA issues Form-483 with 5 observations to Ajanta Pharma's Paithan facility
Ajanta Pharma said the US FDA has issued Form-483 with five observations after inspecting its Paithan manufacturing facility in Maharashtra from April 13–21, 2026. The company stated it will respond within the stipulated timeframe, while noting that Form-4
Announcement as on 22 April 2026

Tech Mahindra Q4 Results: Cons profit rises 16% YoY to Rs 1,354 crore, revenue up 13%; co declares Rs 36/share dividend
Tech Mahindra Q4 Results: Tech Mahindra reported a 16% year-on-year increase in net profit to Rs 1,354 crore for the March quarter, with revenue rising 13% to Rs 15,076 crore. The company is accelerating its AI-led transition, achieving its highest deal wi
Announcement as on 22 April 2026

Obesity drug market to gain as Indians pop the pill and Chinese bring more
India's obesity treatment market is set for a major shift by year-end. A wave of oral GLP1 weight-loss pills, including those from China, will soon be available. These pills offer a cheaper and easier alternative to injections. Experts anticipate greater p
Announcement as on 22 April 2026

Announcements by S&p Developed Ex-u.s.bmi [capped] first page | Next page | Prev page |

SW0I S&p Developed Ex-u.s.bmi [capped] current price & indicator signals

Moving Averages for S&p Developed Ex-u.s.bmi [capped]

  • 5Day Average: 460.16
  • 12Day Average: 445.2
  • 20Day Average: 428.17
  • 50Day Average: 383.23
  • 100Day Average: 362.32
  • 150Day Average: 340.52
  • 200Day Average: 320.7

SW0I Indicators & signals

Indicator MACD (12,26,9)

445.04, 422.03, 21.62
Indicator MACD is in positive zone

Indicator ADX (14)

29.86, 33.58, 18.14
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 48
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of SW0I S&p Developed Ex-u.s.bmi [capped] are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
15 Fri May 2026 448.25 445.60 to 472.71 -4.98% 0 times
14 Thu May 2026 471.73 463.34 to 472.03 1.79% 0 times
13 Wed May 2026 463.45 442.77 to 463.98 2.35% 0 times
12 Tue May 2026 452.80 451.29 to 469.58 -2.53% 0 times
11 Mon May 2026 464.56 454.77 to 468.99 2.28% 0 times
08 Fri May 2026 454.22 445.84 to 455.71 0.14% 0 times
07 Thu May 2026 453.59 443.79 to 456.11 2.34% 0 times
06 Wed May 2026 443.21 418.95 to 447.14 0% 0 times
06 Wed May 2026 443.21 418.95 to 447.14 5.52% 0 times
05 Tue May 2026 420.02 417.49 to 421.22 0.15% 0 times
04 Mon May 2026 419.39 408.33 to 421.40 2.79% 0 times
01 Fri May 2026 408.02 406.06 to 409.49 0.64% 0 times

Videos related to: SW0I announcements S&p Developed Ex-u.s.bmi [capped] announcements and dividends declared INDICES

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

SW0I announcements S&p Developed Ex-u.s.bmi [capped] announcements and dividends declared INDICES

 

Back to top